Singh Biotechnology (SBT) is a privately held company based in Tampa Bay, Florida.
SBT is pioneering the development of unique therapeutic agents to treat diseases with great unmet need.
We use our in-house, technology platform to engineer first-in-class sdAbs capable of penetrating the cell membrane and crossing the blood brain barrier.
Our mono-specific and bi-specific antibodies are designed to directly target intracellular proteins central to the pathogenesis of disease.
SBT’s technology platform and therapeutic agents have all been developed internally, and have not been licensed from any third party.
